Aglaia Moreira Garcia Ximenes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aglaia Moreira Garcia Ximenes has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Antonio José Maria Cataneo
Universidade Estadual Paulista (UNESP)
2 shared publications - Daniele Cristina Cataneo
UNESP, Brasil
2 shared publications - Erica Nishida Hasimoto
Botucatu Faculty of Medicine, Medical School, Sao Paulo State University Julio de Mesquita Filho, Botucatu/SP - CEP, 18618687, Brazil
2 shared publications - Diana Rodrigues de Pina
São Paulo State University (UNESP)
1 shared publication - Fabio Nishida Hasimoto
Post-Graduation Program on General Basis of Surgery, School of Medicine, São Paulo State University-UNESP, Botucatu, SP, CEP 18618-970, Brazil
1 shared publication - Ivana Teixeira de Aguiar
Botucatu Faculty of Medicine, Medical School, Sao Paulo State University Julio de Mesquita Filho, Botucatu/SP - CEP, 18618687, Brazil
1 shared publication
Latest Publications
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 21 (3) , 227-235
Machine Learning to Differentiate Malignant and Non-malignant Pleural Effusion Findings
Introduction: This study developed a method using machine learning techniques to differentiate between malignant and non-malignant pleural effusions, analyzing texture parameters in computed tomography scans. Method: The study involved forty-one patients, with their computed tomography examinations classified into three groups: True Positive - patients with both cytopathological analysis and pleural biopsy indicating malignancy; True Negative - patients with negative results in both tests; and False Negative - patients with negative cytopathological analysis but positive pleural biopsy results. Four machine learning methods were applied across three analyses: True Positive versus True Negative, True Positive versus False Negative, and True Negative versus False Negative. The logistic regression model demonstrated notable effectiveness, achieving an Area Under the Curve of 0.84 ± 0.02 in the True Positive versus True Negative analysis and 0.81 ± 0.05 in the True Positive versus False Negative comparison. In the True Negative versus False Negative analysis, the Naive Bayes model achieved an Area Under the Curve of 0.72 ± 0.02. Results: Statistically significant differences were observed in the liquid Lactate Dehydrogenase and protein content between the True Positive and True Negative groups (p-values of 0.0390 and 0.0249, respectively), and in the liquid pH level between the True Positive and False Negative groups (p-value of 0.0254). The use of textural features in combination with machine learning techniques provided a reliable classification for investigating suspected pleural effusion findings. This method represents a potential tool for assisting in clinical diagnosis and decision-making, enhancing the accuracy of pleural effusion assessments. Conclusion: In conclusion, our approach not only improves diagnostic accuracy but also offers a faster and non-invasive alternative, significantly benefiting clinical decision-making and patient care.
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 21 (3) , 227-235
Machine Learning to Differentiate Malignant and Non-malignant Pleural Effusion Findings
Introduction: This study developed a method using machine learning techniques to differentiate between malignant and non-malignant pleural effusions, analyzing texture parameters in computed tomography scans. Method: The study involved forty-one patients, with their computed tomography examinations classified into three groups: True Positive - patients with both cytopathological analysis and pleural biopsy indicating malignancy; True Negative - patients with negative results in both tests; and False Negative - patients with negative cytopathological analysis but positive pleural biopsy results. Four machine learning methods were applied across three analyses: True Positive versus True Negative, True Positive versus False Negative, and True Negative versus False Negative. The logistic regression model demonstrated notable effectiveness, achieving an Area Under the Curve of 0.84 ± 0.02 in the True Positive versus True Negative analysis and 0.81 ± 0.05 in the True Positive versus False Negative comparison. In the True Negative versus False Negative analysis, the Naive Bayes model achieved an Area Under the Curve of 0.72 ± 0.02. Results: Statistically significant differences were observed in the liquid Lactate Dehydrogenase and protein content between the True Positive and True Negative groups (p-values of 0.0390 and 0.0249, respectively), and in the liquid pH level between the True Positive and False Negative groups (p-value of 0.0254). The use of textural features in combination with machine learning techniques provided a reliable classification for investigating suspected pleural effusion findings. This method represents a potential tool for assisting in clinical diagnosis and decision-making, enhancing the accuracy of pleural effusion assessments. Conclusion: In conclusion, our approach not only improves diagnostic accuracy but also offers a faster and non-invasive alternative, significantly benefiting clinical decision-making and patient care.
- 24 September 2019
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 30 (2) , 111-120
Radiofrequency in the treatment of primary hyperhidrosis: systematic review and meta-analysis
To evaluate, via a systematic review, the effectiveness of radiofrequency (RF) for treatment of primary hyperhidrosis (PH).
- 24 September 2019
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 30 (2) , 111-120
Radiofrequency in the treatment of primary hyperhidrosis: systematic review and meta-analysis
To evaluate, via a systematic review, the effectiveness of radiofrequency (RF) for treatment of primary hyperhidrosis (PH).
- Open Access
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (6) , 486-490
Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study
Objective: To evaluate the efficacy of mitomycin C (MMC) in the endoscopic treatment of tracheal stenosis. Methods: Patients with laryngotracheal, tracheal, or tracheobronchial stenosis were treated with dilation and topical MMC. The inclusion criteria were as follows: being ineligible for surgery (for medical reasons) at the time of evaluation; membranous stenosis responding well to dilation; and postoperative stenosis at the anastomosis site. Etiology of stenosis and indication for treatment with MMC, as well as site, length, and percentage of stenosis, together with presence of tracheostomy and duration of follow-up, were analyzed. The outcomes evaluated were symptom-free interval ≥ 12 months, number of dilations with topical application of MMC, and complications. Results: Twenty-two patients (15 men and 7 women) were treated between 2003 and 2010. Stenosis was due to endotracheal intubation in 15 patients and surgery in 8. Pure tracheal stenosis was encountered in 13 patients, subglottic stenosis was encountered in 4, tracheobronchial stenosis was encountered in 3, and complex stenosis was encountered in 2. The length of stenosis ranged from 0.5 cm to 2.5 cm, and the percentage of stenosis ranged from 40% to 100%. Nine patients had undergone tracheostomy and had a Montgomery T-tube in situ. Treatment was successful in 14 patients, who remained free of symptoms for at least 12 months. The number of topical applications of MMC ranged from 1 to 5, and complications included fungal infection, keloid scarring, granuloma, and mediastinal emphysema. Conclusions: MMC appears to be effective in the endoscopic treatment of tracheal stenosis.
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (6) , 486-490
Open AccessMitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study
Objective: To evaluate the efficacy of mitomycin C (MMC) in the endoscopic treatment of tracheal stenosis. Methods: Patients with laryngotracheal, tracheal, or tracheobronchial stenosis were treated with dilation and topical MMC. The inclusion criteria were as follows: being ineligible for surgery (for medical reasons) at the time of evaluation; membranous stenosis responding well to dilation; and postoperative stenosis at the anastomosis site. Etiology of stenosis and indication for treatment with MMC, as well as site, length, and percentage of stenosis, together with presence of tracheostomy and duration of follow-up, were analyzed. The outcomes evaluated were symptom-free interval ≥ 12 months, number of dilations with topical application of MMC, and complications. Results: Twenty-two patients (15 men and 7 women) were treated between 2003 and 2010. Stenosis was due to endotracheal intubation in 15 patients and surgery in 8. Pure tracheal stenosis was encountered in 13 patients, subglottic stenosis was encountered in 4, tracheobronchial stenosis was encountered in 3, and complex stenosis was encountered in 2. The length of stenosis ranged from 0.5 cm to 2.5 cm, and the percentage of stenosis ranged from 40% to 100%. Nine patients had undergone tracheostomy and had a Montgomery T-tube in situ. Treatment was successful in 14 patients, who remained free of symptoms for at least 12 months. The number of topical applications of MMC ranged from 1 to 5, and complications included fungal infection, keloid scarring, granuloma, and mediastinal emphysema. Conclusions: MMC appears to be effective in the endoscopic treatment of tracheal stenosis.